The CDC's Influenza Division intends to issue a sole-source, firm-fixed-price order to Miltenyi Biotec Inc. for a GentleMACS Octo Dissociator system with a service plan. The justification is that this specific instrument is the only commercially available system that meets all technical requirements, including processing eight samples in a closed sterile system with integrated heating and validated protocols. Its proprietary, patented design ensures reproducible sample preparation and it is uniquely compatible with existing laboratory SOPs and downstream workflows. The government's intent to solicit only one source is based on these unique capabilities. Quotations from other parties will be considered if received within 15 days of the notice's issuance for the purpose of determining whether to conduct a competitive procurement.